TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27164847

Group type: EXPERIMENTAL
Intervention: Sexual and alcohol risk reduction (NLITEN) condition
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 228
Study: 24297949

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: ERG-positive patients
Number of subjects: 1590

Group type: COMPARATOR
Intervention: ERG-negative patients
Number of subjects: 1590
Study: 23166914

Group type: EXPERIMENTAL
Intervention: IPARZINE‐4A‐SKR topical agent
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 20088409

Group type: EXPERIMENTAL
Intervention: GABA drink (1000 mg of GABA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (sports drink of 200 mL)
Number of subjects: 8
Study: 16544102

Group type: EXPERIMENTAL
Intervention: PSTE (2.5 g)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: PSTA (2.5 g)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (no PSTE/PSTA)
Number of subjects: 7
Study: 15131445

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs) in spine surgery
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Studies reporting sample size calculation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Studies explicitly stating a primary outcome
Number of subjects: 37
Study: 11337644

Group type: EXPERIMENTAL
Intervention: Hollow intubating introducer (HII) placed in trachea (Group T)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hollow intubating introducer (HII) positioned in the esophagus (Group E)
Number of subjects: 100
Study: 9042123

Group type: EXPERIMENTAL
Intervention: 80%:20% helium-oxygen gas mixture (HELIOX)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 18
Study: 7910127

Group type: EXPERIMENTAL
Intervention: Levosulpiride 25 mg 3 times daily for 30 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Domperidone 10 mg 3 times daily for 30 days
Number of subjects: 50
Study: 3150693

Group type: EXPERIMENTAL
Intervention: Haloperidol plus lithium
Number of subjects: 36

Group type: COMPARATOR
Intervention: Haloperidol plus placebo
Number of subjects: 36
Study: 31322799

Group type: EXPERIMENTAL
Intervention: Data-driven self-calibration and reconstruction approach
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional approach using iterative self-calibration and reconstruction with parallel imaging and compressed sensing
Number of subjects: 29
Study: 30153265

Group type: EXPERIMENTAL
Intervention: Crowdsourced HIV intervention (multimedia HIV testing campaign, online HIV testing service, local testing promotion campaigns)
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Crowdsourced HIV intervention
Number of subjects: 1381
Study: 28213593

Group type: EXPERIMENTAL
Intervention: VVZ-149 with intravenous (IV) hydromorphone patient-controlled analgesia (PCA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: IV PCA alone (control)
Number of subjects: 120
Study: 26179984

Group type: EXPERIMENTAL
Intervention: Retromuscular synthetic mesh (study group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No mesh (control group)
Number of subjects: 58
Study: 23335089

Group type: EXPERIMENTAL
Intervention: 1α-hydroxyvitamin D2 (1α‐OH‐D2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21741804

Group type: EXPERIMENTAL
Intervention: High-dose hydrocortisone (100-140 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 18182271

Group type: EXPERIMENTAL
Intervention: Entropy monitoring (G2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No entropy monitoring (G1)
Number of subjects: 32
Study: 16679811

Group type: EXPERIMENTAL
Intervention: Total laryngectomy
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: CO(2) laser microsurgical partial laryngectomy
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Open partial laryngectomy
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 146
Study: 15324486

Group type: EXPERIMENTAL
Intervention: TJ-29 (3.0 g thrice daily for 7 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11227677

Group type: EXPERIMENTAL
Intervention: OAC-I (6 weeks of 'A' formulation of omeprazole [20 mg twice daily] plus 2 weeks of amoxicillin [1.0 g twice daily] and clarithromycin [500 mg twice daily])
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: OAC-II (6 weeks of 'B' formulation of omeprazole [20 mg twice daily] plus 2 weeks of the same antibiotics)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: OAC-I
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: OAC-II
Number of subjects: 74
Study: 9286938

Group type: EXPERIMENTAL
Intervention: xemilofiban 10 mg P.O. BID or higher
Number of subjects: 170

Group type: COMPARATOR
Intervention: placebo (250 mg ticlopidine P.O. BID)
Number of subjects: 170
Study: 8326539

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (150,000 units IM on day 1 followed by 15,000 units orally for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine appropriate treatment (may include 3000 units vitamin A per day)
Number of subjects: 0
Study: 3553492

Group type: EXPERIMENTAL
Intervention: Relaxation and stress-management training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31992840

Group type: EXPERIMENTAL
Intervention: IL7Rp mutated (IL7Rpmut) T-ALL
Number of subjects: 200

Group type: COMPARATOR
Intervention: IL7Rp non-mutated (IL7RpWT) T-ALL
Number of subjects: 200

Group type: COMPARATOR
Intervention: Allogeneic hematopoietic stem cell transplantation (HSCT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Post-induction chemotherapy regimens
Number of subjects: 200
Study: 30943878

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery plus thrombolysis
Number of subjects: 500

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 500
Study: 28320081

Group type: EXPERIMENTAL
Intervention: Roux‐en‐Y gastric bypass (RYGB)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Weight loss (WL) camp
Number of subjects: 209

Group type: COMPARATOR
Intervention: Residential intermittent programme
Number of subjects: 209

Group type: COMPARATOR
Intervention: Hospital outpatient programme
Number of subjects: 209
Study: 25425058

Group type: EXPERIMENTAL
Intervention: lercanidipine 20 mg/day
Number of subjects: 104

Group type: COMPARATOR
Intervention: amlodipine 10 mg/day
Number of subjects: 104
Study: 23462586

Group type: EXPERIMENTAL
Intervention: B-group vitamins and antioxidant vitamins (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (n = 50)
Number of subjects: 100
Study: 21911597

Group type: EXPERIMENTAL
Intervention: FTY720 2.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0
Study: 19372098

Group type: EXPERIMENTAL
Intervention: betaxolol
Number of subjects: 1352

Group type: COMPARATOR
Intervention: metoprolol
Number of subjects: 1352
Study: 16329161

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (120 mg per day)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 15570185

Group type: EXPERIMENTAL
Intervention: Limited sampling strategy for MPA
Number of subjects: 136
Study: 11333838

Group type: EXPERIMENTAL
Intervention: Estrogen administration
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Spontaneous weight gain
Number of subjects: 27
Study: 9203669

Group type: EXPERIMENTAL
Intervention: Live attenuated varicella vaccine (3625 pfu)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partially heat-inactivated vaccine (1125 pfu)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partially heat-inactivated vaccine (439 pfu)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8213445

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 25
Study: 3677376

Group type: EXPERIMENTAL
Intervention: Intracoronary urokinase (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional therapy (group B)
Number of subjects: 20
Study: 30730838

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined group (nature sounds + reflexology)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nature sounds
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 27749154

Group type: EXPERIMENTAL
Intervention: RTP+Myomo therapy (repetitive task-specific practice with myoelectric brace)
Number of subjects: 12

Group type: COMPARATOR
Intervention: RTP only (repetitive task-specific practice)
Number of subjects: 12
Study: 25748612

Group type: EXPERIMENTAL
Intervention: Statin therapy (specific trials: JUPITER and ASCOT for primary prevention; CARE and PROVE IT‐TIMI 22 for secondary prevention)
Number of subjects: 48421

Group type: EXPERIMENTAL
Intervention: Statin therapy (specific trials: JUPITER and ASCOT for primary prevention)
Number of subjects: 48421

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 48421
Study: 22762723

Group type: EXPERIMENTAL
Intervention: Interdisciplinary team-based 'geriatric' care model by non-geriatrics specialist physicians
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21878743

Group type: EXPERIMENTAL
Intervention: Bolus rapid-acting insulin analogues
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control subjects with normal glucose tolerance
Number of subjects: 10
Study: 18640810

Group type: EXPERIMENTAL
Intervention: Partial breast irradiation with high-dose-rate brachytherapy (4 Gy twice a day for 4 days, total dose 32 Gy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Patients implanted during surgery
Number of subjects: 80
Study: 17563214

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 15957245

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (20 g/day for 5 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 12145915

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.4 mg/kg BW
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.3 mg/kg BW
Number of subjects: 329

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 329
Study: 11913409

Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + MPA 2.5 mg
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + MPA 5.0 mg
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + MPA 10 mg
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 568
Study: 8029670

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 565
Study: 2685142

Group type: EXPERIMENTAL
Intervention: OK-432 (5 KE, administered by intramuscular injection every other day for up to 5 years)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 215
Study: 943472

Group type: EXPERIMENTAL
Intervention: Heterosexual romantic films
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group sex mild (two males and one female)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heterosexual genital films
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group sex explicit (three males and three females)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sadomasochism mild
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sadomasochism explicit (forcing and brutal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Male homosexuality
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correlation between ratings of group sex films and rejection of sexual myths
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correlation between rated degree of sexual stimulation for heterosexual and group sex films
Number of subjects: 20
Study: 31093662

Group type: EXPERIMENTAL
Intervention: Heparin dose <70 U/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin dose 70-100 U/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin dose >100 U/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT <250 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT 250-350 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT >350 s
Number of subjects: 0
Study: 31472360

Group type: EXPERIMENTAL
Intervention: Wireless CRT system (therapy on)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Sham control (therapy off)
Number of subjects: 350
Study: 27933333

Group type: EXPERIMENTAL
Intervention: BCF indices (I30/I0, CP30/CP0, ΔI30/ΔG30, ΔCP30/ΔG30, corrected insulin response at 30 min) for incident type 2 diabetes
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Disposition indices (BCF index × Matsuda index)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: All ROC AUCs for incident prediabetes
Number of subjects: 476

Group type: COMPARATOR
Intervention: Matsuda index
Number of subjects: 476
Study: 25331843

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 126
Study: 23842141

Group type: EXPERIMENTAL
Intervention: HDL levels <40 mg/dL
Number of subjects: 113

Group type: COMPARATOR
Intervention: HDL levels >40 mg/dL
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: HDL levels >60 mg/dL
Number of subjects: 113
Study: 22187278

Group type: EXPERIMENTAL
Intervention: Chlorthalidone-based stepped-care therapy (active treatment)
Number of subjects: 4736

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study: 19301378

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasmapheresis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other agents (cyclophosphamide, rituximab, azathioprine, cyclosporine, interferons, fludarabine, mycophenolate mofetil, etanercept)
Number of subjects: 0
Study: 16269179

Group type: EXPERIMENTAL
Intervention: Prednisolone (1mg/kg/day for 10 days, followed by tapering over 4 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (anti-epileptic monotherapy)
Number of subjects: 60
Study: 15327804

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg twice a day
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice a day
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 10654905

Group type: EXPERIMENTAL
Intervention: Intracavernosal alprostadil (EDEX)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Intraurethral alprostadil (MUSE)
Number of subjects: 111
Study: 9052354

Group type: EXPERIMENTAL
Intervention: 1‐123‐metaiodobenzylguanidine (MIBG) scintigraphy
Number of subjects: 0
Study: 8337465

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Nifedipine retard
Number of subjects: 185
Study: 3896662

Group type: EXPERIMENTAL
Intervention: Tenoxicam (40 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Piroxicam (40 mg/day)
Number of subjects: 30
Study: 29926653

Group type: EXPERIMENTAL
Intervention: Health Qigong Baduanjin exercise for 24 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study: 27236412

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Risperidone long-acting injection (RLAI)
Number of subjects: 30
Study: 25543612

Group type: EXPERIMENTAL
Intervention: Sonic endo‐instruments in combination with Mtwo Ni‐Ti files
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stainless‐steel files
Number of subjects: 100
Study: 21030367

Group type: EXPERIMENTAL
Intervention: Therapeutic Assessment (TA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Assessment as Usual (AAU)
Number of subjects: 70
Study: 16200755

Group type: EXPERIMENTAL
Intervention: Robot devices for wrist rehabilitation (G1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Robot devices for elbow-shoulder rehabilitation (G2)
Number of subjects: 16
Study: 12207774

Group type: EXPERIMENTAL
Intervention: oral allopurinol (15 mg/kg/day) for 3 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: intramuscular injection of Glucantime (30 mg/kg/day) for 2 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: combined therapy with allopurinol plus Glucantime
Number of subjects: 150
Study: 9579010

Group type: EXPERIMENTAL
Intervention: Counseling + Active Nicotine Patch (CAP)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Counseling + Placebo Patch (CPP)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Minimal Care (MC)
Number of subjects: 185
Study: 7698030

Group type: EXPERIMENTAL
Intervention: 55% carbohydrate diet
Number of subjects: 0
Study: 2523720

Group type: EXPERIMENTAL
Intervention: GR 38032F
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 0
Study: 320916

Group type: EXPERIMENTAL
Intervention: clemastine fumarate 2.68 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: chlorpheniramine 4 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study: 29061540

Group type: EXPERIMENTAL
Intervention: Suspicious digital rectal examination
Number of subjects: 35350

Group type: COMPARATOR
Intervention: Normal prostate specific antigen (<2 ng/ml)
Number of subjects: 35350

Group type: COMPARATOR
Intervention: Elevated prostate specific antigen (≥3 ng/ml)
Number of subjects: 35350

Group type: COMPARATOR
Intervention: Equivocal prostate specific antigen (2-3 ng/ml)
Number of subjects: 35350
Study: 27625085

Group type: EXPERIMENTAL
Intervention: Robotic total thyroidectomy with CND via bilateral axillo-breast approach (BABA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional open procedure
Number of subjects: 100
Study: 25720440

Group type: EXPERIMENTAL
Intervention: Transparent urinary tract simulator (experimental group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Opaque plastic urinary tract simulator (control group)
Number of subjects: 160
Study: 24156019

Group type: EXPERIMENTAL
Intervention: Mitoxantrone/prednisone/custirsen (MPC)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Docetaxel retreatment/prednisone/custirsen (DPC)
Number of subjects: 67
Study: 19911223

Group type: EXPERIMENTAL
Intervention: TT technique (2 trocars in the umbilicus)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: TT technique
Number of subjects: 32

Group type: COMPARATOR
Intervention: ST technique (single-trocar)
Number of subjects: 32

Group type: COMPARATOR
Intervention: ST technique
Number of subjects: 32
Study: 17971715

Group type: EXPERIMENTAL
Intervention: TDF/FTC and EFV
Number of subjects: 0

Group type: COMPARATOR
Intervention: ZDV/3TC and EFV
Number of subjects: 0
Study: 16644630

Group type: EXPERIMENTAL
Intervention: Deltec Cozmo insulin pump with meal bolus alarms (experimental group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Current insulin pumps without meal bolus alarms (control group)
Number of subjects: 48
Study: 12806326

Group type: EXPERIMENTAL
Intervention: Airborne particle abrasion with 50‐microm aluminum oxide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10% hydrofluoric acid etching
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (specimens without additional surface treatments)
Number of subjects: 30
Study: 10992835

Group type: COMPARATOR
Intervention: Cricoid pressure (Group C)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sham pressure (Group S)
Number of subjects: 70
Study: 8976723

Group type: COMPARATOR
Intervention: Topical placebo
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids without acyclovir
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids and oral acyclovir
Number of subjects: 260
Study: 1535485

Group type: EXPERIMENTAL
Intervention: Isoflurane 1% and alfentanil 10 micrograms.kg‐1 as a bolus and 10 micrograms.kg‐1.h‐1 infusion (group IA)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Propofol 9 mg.kg‐1.h‐1 infusion decreasing to 6 mg.kg‐1.h‐1 and alfentanil 10 micrograms.kg‐1.h‐1 (group PA)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Isoflurane (group IO)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Propofol (group PO)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Matched control group of 25 females (not anaesthetised)
Number of subjects: 114
Study: 6747766

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atropine 0.01 mg/kg plus Pancuronium 0.1 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: No medication (controls)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 30868125

Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Medium Chain Triglycerides (MCTs)
Number of subjects: 34
Study: 30942961

Group type: EXPERIMENTAL
Intervention: Adhesive 1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Adhesive 2
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Adhesive 3
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 48

Group type: COMPARATOR
Intervention: No Adhesive
Number of subjects: 48
Study: 27658873

Group type: EXPERIMENTAL
Intervention: Intervention group (multicomponent intervention)
Number of subjects: 12024

Group type: COMPARATOR
Intervention: Control group (standard of care)
Number of subjects: 12024
Study: 24939355

Group type: EXPERIMENTAL
Intervention: Self-study group using MP3 players containing heart sound audio files
Number of subjects: 83

Group type: COMPARATOR
Intervention: Multimedia lecture group receiving a 1-time 1-hour higher cognitive load lecture using the same audio files
Number of subjects: 83
Study: 22381949

Group type: EXPERIMENTAL
Intervention: moclobemide (400 mg)
Number of subjects: 117

Group type: COMPARATOR
Intervention: clomipramine (150 mg)
Number of subjects: 117
Study: 20467014

Group type: EXPERIMENTAL
Intervention: Multimodal optimization of surgical care
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional perioperative management
Number of subjects: 63
Study: 17983723

Group type: EXPERIMENTAL
Intervention: BPS intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42